Hepatocyte-specific loss of LAP2α protects against diet-induced hepatic steatosis and steatohepatitis in male mice
Preprint
Abstract
There is increasing evidence for the importance of the nuclear envelope in lipid metabolism, nonalcoholic fatty liver disease (NAFLD), and nonalcoholic steatohepatitis (NASH). Human mutations in LMNA , encoding A-type nuclear lamins, cause early-onset insulin resistance and NASH, while hepatocyte-specific deletion of Lmna predisposes to NASH with fibrosis in male mice. Given that variants in the gene encoding LAP2α, a nuclear protein that regulates lamin A/C, were previously identified in patients with NAFLD, we sought to determine the role of LAP2α in NAFLD using a mouse genetic model. Hepatocyte-specific Lap2a-knockout ( Lap2α (ΔHep) ) mice and littermate controls were fed normal chow or high-fat diet (HFD) for 8 weeks or 6 months. In contrast to what was observed with hepatocyte-specific Lmna deletion, male Lap2a (ΔHep) mice showed no increase in hepatic steatosis or NASH compared to controls. Rather, Lap2a (ΔHep) mice demonstrated reduced hepatic steatosis, particularly after long-term HFD, with decreased susceptibility to diet-induced NASH. Accordingly, whereas pro-steatotic genes Cidea, Mogat1 , and Cd36 were upregulated in Lmnα -KO mice, they were downregulated in Lap2α (ΔHep) mice, and there was a trend toward decreases in pro-inflammatory and pro-fibrotic genes. These data indicate that hepatocyte-specific Lap2a deletion protects against hepatic steatosis and NASH in mice; therefore, LAP2α might represent a potential therapeutic target in human NASH. Brief Summary: Loss of LAP2α in mouse hepatocytes protected against diet-induced hepatic steatosis and NASH.Keywords
This publication has 46 references indexed in Scilit:
- Ethnicity and nonalcoholic fatty liver diseaseHepatology, 2011
- Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis CGut, 2011
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic SteatohepatitisNew England Journal of Medicine, 2010
- Lamina-Associated Polypeptide 2α Loss Impairs Heart Function and Stress Response in MiceCirculation Research, 2010
- Cidea is associated with lipid droplets and insulin sensitivity in humansProceedings of the National Academy of Sciences, 2008
- Alterations in mitosis and cell cycle progression caused by a mutant lamin A known to accelerate human agingProceedings of the National Academy of Sciences, 2007
- Nucleoplasmic LAP2α–lamin A complexes are required to maintain a proliferative state in human fibroblastsJournal of Cell Biology, 2007
- Lamina-associated polypeptide 2α regulates cell cycle progression and differentiation via the retinoblastoma–E2F pathwayJournal of Cell Biology, 2006
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005
- Dual Roles for Glucokinase in Glucose Homeostasis as Determined by Liver and Pancreatic β Cell-specific Gene Knock-outs Using Cre RecombinaseJournal of Biological Chemistry, 1999